Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Int J Dermatol ; 54(2): 188-92, 2015 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-24962008

RESUMEN

BACKGROUND: There are no reliable epidemiological data on sarcoidosis in the French West Indies, although this disease is known to be more frequent and more severe in Black African-Americans and West Indians. OBJECTIVES: This retrospective study aimed to assess the incidence and prevalence of sarcoidosis in Guadeloupe over a 7-year period and to determine its epidemiological, clinical, and evolutionary characteristics. METHODS: Patients were identified through the computerized databases of the three pathology laboratories and two hospitals on the islands of Guadeloupe. Histologically proven cases of sarcoidosis were selected. All patients were recalled at a single study time-point. RESULTS: A total of 75 patients were identified. These included 44 women and 31 men (sex ratio: 1.4), with a mean ± standard deviation (SD) age of 47 ± 14 years and Fitzpatrick skin types IV-VI. The average incidence was 2.28 per 100,000 inhabitants per year (95% confidence interval [CI] 1.69-3.02). The prevalence of sarcoidosis in 2009 was 21.09 per 100,000 inhabitants (95% CI 16.00-26.18). Most patients (61/71, 85.9%) exhibited multiple organ involvement; the mean ± SD number of organs involved was 2.6 ± 1.1. The initiation of systemic therapy was required in 75.7% of cases. Several lines of treatment were necessary in 41.5% of affected patients. At the study time-point, seven patients were found to have died. Four of these deaths were directly attributable to sarcoidosis (mortality rate: 5.3%). CONCLUSIONS: This epidemiological study on sarcoidosis in Guadeloupe reveals a low incidence of the disease and a high degree of severity as evidenced by the average number of affected organs, the high frequency of extrathoracic organ involvement, the frequent use of corticosteroids, and a mortality rate of 5.3%.


Asunto(s)
Enfermedades del Sistema Nervioso Central/etnología , Hepatopatías/etnología , Sarcoidosis/etnología , Enfermedades de la Piel/etnología , Adulto , África/etnología , Región del Caribe/etnología , Femenino , Guadalupe/epidemiología , Humanos , Incidencia , Masculino , Persona de Mediana Edad , Prevalencia , Estudios Retrospectivos , Sarcoidosis/tratamiento farmacológico , Sarcoidosis/mortalidad , Sarcoidosis Pulmonar/etnología
2.
Arch Neurol ; 45(7): 777-80, 1988 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-3291833

RESUMEN

Neurocysticercosis is no longer a medical curiosity in the United States. Two hundred thirty-eight patients with neurocysticercosis were studied between 1981 and 1986 at the Los Angeles County-University of Southern California Medical Center, Los Angeles. Presenting signs and symptoms were protean--ranging from a single convulsion to coma and death. Fifty-one patients (21%) presented with an acute increase in intracranial pressure. There were 71 patients who ultimately required a shunting procedure or craniotomy. Presentation, diagnosis, management, and laboratory adjuncts (the role of cysticercosis titers and the electroencephalogram) are discussed. Mortality and morbidity can be reduced by maintaining a high degree of suspicion in populations at increased risk for cysticercosis.


Asunto(s)
Enfermedades del Sistema Nervioso Central/complicaciones , Cisticercosis/complicaciones , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Anticonvulsivantes/uso terapéutico , Enfermedades del Sistema Nervioso Central/etnología , Enfermedades del Sistema Nervioso Central/terapia , Derivaciones del Líquido Cefalorraquídeo , Niño , Preescolar , Craneotomía , Cisticercosis/etnología , Cisticercosis/terapia , Electroencefalografía , Femenino , Hispánicos o Latinos , Humanos , Hidrocefalia/complicaciones , Hidrocefalia/cirugía , Masculino , México/etnología , Persona de Mediana Edad
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA